Trials / Conditions / Recurrent Pancreatic Neuroendocrine Carcinoma
Recurrent Pancreatic Neuroendocrine Carcinoma
3 registered clinical trials studyying Recurrent Pancreatic Neuroendocrine Carcinoma.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Cixutumumab, Everolimus, and Octreotide Acetate in Treating Patients With Advanced Low to Intermediate Grade N NCT01204476 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Isl NCT01010126 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Pazopanib Hydrochloride in Treating Patients With Advanced Neuroendocrine Cancer NCT00454363 | National Cancer Institute (NCI) | Phase 2 |